W Gerald Teague1, Monica G Lawrence2, Debbie-Ann T Shirley3, Andrea S Garrod3, Stephen V Early4, Jackie B Payne3, Julia A Wisniewski3, Peter W Heymann3, James J Daniero4, John W Steinke2, Deborah K Froh3, Thomas J Braciale5, Michael Ellwood6, Drew Harris7, Larry Borish8. 1. Child Health Research Center, Division of Respiratory Medicine, Allergy, and Immunology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Va. Electronic address: wgt2p@virginia.edu. 2. Division of Allergy, Asthma, and Immunology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Va. 3. Child Health Research Center, Division of Respiratory Medicine, Allergy, and Immunology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Va. 4. Department of Otolaryngology, Head and Neck Surgery, University of Virginia School of Medicine, Charlottesville, Va. 5. Beirne Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Va. 6. University Physicians Group, University of Virginia School of Medicine, Charlottesville, Va. 7. Division of Respiratory and Critical Care Medicine, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Va. 8. Division of Allergy, Asthma, and Immunology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Va; Beirne Carter Immunology Center, University of Virginia School of Medicine, Charlottesville, Va; Department of Microbiology, University of Virginia School of Medicine, Charlottesville, Va.
Abstract
BACKGROUND: Children with severe asthma have frequent exacerbations despite guidelines-based treatment with high-dose corticosteroids. The importance of refractory lung inflammation and infectious species as factors contributing to poorly controlled asthma in children is poorly understood. OBJECTIVE: To identify prevalent granulocyte patterns and potential pathogens as targets for revised treatment, 126 children with severe asthma underwent clinically indicated bronchoscopy. METHODS: Diagnostic tests included bronchoalveolar lavage (BAL) for cell count and differential, bacterial and viral studies, spirometry, and measurements of blood eosinophils, total IgE, and allergen-specific IgE. Outcomes were compared among 4 BAL granulocyte patterns. RESULTS: Pauci-granulocytic BAL was the most prevalent granulocyte category (52%), and children with pauci-granulocytic BAL had less postbronchodilator airflow limitation, less blood eosinophilia, and less detection of BAL enterovirus compared with children with mixed granulocytic BAL. Children with isolated neutrophilia BAL were differentiated by less blood eosinophilia than those with mixed granulocytic BAL, but greater prevalence of potential bacterial pathogens compared with those with pauci-granulocytic BAL. Children with isolated eosinophilia BAL had features similar to those with mixed granulocytic BAL. Children with mixed granulocytic BAL took more maintenance prednisone, and had greater blood eosinophilia and allergen sensitization compared with those with pauci-granulocytic BAL. CONCLUSIONS: In children with severe, therapy-resistant asthma, BAL granulocyte patterns and infectious species are associated with novel phenotypic features that can inform pathway-specific revisions in treatment. In 32% of children evaluated, BAL revealed corticosteroid-refractory eosinophilic infiltration amenable to anti-TH2 biological therapies, and in 12%, a treatable bacterial pathogen.
BACKGROUND:Children with severe asthma have frequent exacerbations despite guidelines-based treatment with high-dose corticosteroids. The importance of refractory lung inflammation and infectious species as factors contributing to poorly controlled asthma in children is poorly understood. OBJECTIVE: To identify prevalent granulocyte patterns and potential pathogens as targets for revised treatment, 126 children with severe asthma underwent clinically indicated bronchoscopy. METHODS: Diagnostic tests included bronchoalveolar lavage (BAL) for cell count and differential, bacterial and viral studies, spirometry, and measurements of blood eosinophils, total IgE, and allergen-specific IgE. Outcomes were compared among 4 BAL granulocyte patterns. RESULTS: Pauci-granulocytic BAL was the most prevalent granulocyte category (52%), and children with pauci-granulocytic BAL had less postbronchodilator airflow limitation, less blood eosinophilia, and less detection of BAL enterovirus compared with children with mixed granulocytic BAL. Children with isolated neutrophiliaBAL were differentiated by less blood eosinophilia than those with mixed granulocytic BAL, but greater prevalence of potential bacterial pathogens compared with those with pauci-granulocytic BAL. Children with isolated eosinophiliaBAL had features similar to those with mixed granulocytic BAL. Children with mixed granulocytic BAL took more maintenance prednisone, and had greater blood eosinophilia and allergen sensitization compared with those with pauci-granulocytic BAL. CONCLUSIONS: In children with severe, therapy-resistant asthma, BAL granulocyte patterns and infectious species are associated with novel phenotypic features that can inform pathway-specific revisions in treatment. In 32% of children evaluated, BAL revealed corticosteroid-refractory eosinophilic infiltration amenable to anti-TH2 biological therapies, and in 12%, a treatable bacterial pathogen.
Authors: J de Blic; F Midulla; A Barbato; A Clement; I Dab; E Eber; C Green; J Grigg; S Kotecha; G Kurland; P Pohunek; F Ratjen; G Rossi Journal: Eur Respir J Date: 2000-01 Impact factor: 16.671
Authors: Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger Journal: N Engl J Med Date: 2000-10-12 Impact factor: 91.245
Authors: Muriel Le Bourgeois; Maria Goncalves; Laurence Le Clainche; Marie-Rose Benoist; Jean-Christophe Fournet; Pierre Scheinmann; Jacques de Blic Journal: Chest Date: 2002-09 Impact factor: 9.410
Authors: Jacques de Blic; Isabelle Tillie-Leblond; André Bernard Tonnel; Francis Jaubert; Pierre Scheinmann; Philippe Gosset Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Megan N Januska; David L Goldman; Wilmore Webley; W Gerald Teague; Robyn T Cohen; Supinda Bunyavanich; Alfin G Vicencio Journal: Pediatr Pulmonol Date: 2019-11-15
Authors: Monica G Lawrence; W Gerald Teague; Xin Feng; Caitlin Welch; Elaine Etter; Julie Negri; Marthajoy Spano; Kristin Wavell; Thomas Braciale; John W Steinke; Larry Borish Journal: Ann Allergy Asthma Immunol Date: 2021-08-12 Impact factor: 6.347
Authors: Lyndsey M Muehling; Peter W Heymann; Holliday Carper; Deborah D Murphy; Evan Rajadhyaksha; Joshua Kennedy; Stephen V Early; Manuel Soto-Quiros; Lydiana Avila; Lisa Workman; Thomas A E Platts-Mills; Judith A Woodfolk Journal: Clin Exp Allergy Date: 2022-06-06 Impact factor: 5.401
Authors: John W Steinke; Monica G Lawrence; W Gerald Teague; Thomas J Braciale; James T Patrie; Larry Borish Journal: J Allergy Clin Immunol Date: 2020-06-09 Impact factor: 14.290
Authors: Stacey A Gorski; Monica G Lawrence; Amy Hinkelman; MarthaJoy M Spano; John W Steinke; Larry Borish; W Gerald Teague; Thomas J Braciale Journal: PLoS One Date: 2019-08-15 Impact factor: 3.240
Authors: W Gerald Teague; Jaime Mata; Kun Qing; Nicholas J Tustison; John P Mugler; Craig H Meyer; Eduard E de Lange; Yun M Shim; Kristin Wavell; Talissa A Altes Journal: Pediatr Pulmonol Date: 2021-02-23